Utility of Aprepitant in the Management of Pediatric Patients with Cyclical Vomiting Syndrome
<b>Introduction</b>: Cyclical vomiting syndrome (CVS) is a recurrent debilitating illness characterized by intense episodes of nausea and emesis with widely varied pharmacological management across the country. Aprepitant is now increasingly used in patients with CVS. The impact of aprep...
Saved in:
| Main Authors: | Aravind Thavamani, Sindhoosha Malay, Jasmine Khatana, Sujithra Velayuthan, Senthilkumar Sankararaman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Medicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2305-6320/11/8/21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced efficacy of aprepitant-based triple prophylaxis in preventing postoperative nausea and vomiting following metabolic bariatric surgery: a single-center, retrospective cohort study
by: Xiaodong Shan, et al.
Published: (2025-02-01) -
Aprepitant versus Olanzapine in Patients of Breast Cancer on Adriamycin and Cyclophosphamide Regimen – Role in Effectiveness of Prevention of Nausea and Vomiting
by: Indrani Devi Sarma, et al.
Published: (2025-06-01) -
Comparison of aprepitant versus ondansetron for prevention of postoperative nausea and vomiting: A systematic review and meta-analysis with trial sequential analysis
by: Madhusudan P. Singh, et al.
Published: (2024-09-01) -
Precipitants of Cyclic Vomiting
by: J Gordon Millichap
Published: (1998-04-01) -
Aprepitant-loaded solid lipid nanoparticles: a novel approach to enhance oral bioavailability
by: Mazhar Hussain, et al.
Published: (2025-05-01)